We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
-11.26%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.3B
AUM Growth
+$1.07B
(+12%)
Cap. Flow
+$2.36B
Cap. Flow
% of AUM
22.99%
Top 10 Holdings %
Top 10 Hldgs %
47.42%
Holding
1,109
New
276
Increased
252
Reduced
500
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Midstream Partners
WES
|
+$619M |
| 2 |
Cameco
CCJ
|
+$146M |
| 3 |
Hess Midstream
HESM
|
+$80.6M |
| 4 |
Verizon
VZ
|
+$58.6M |
| 5 |
Microsoft
MSFT
|
+$51.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$71M |
| 2 |
Enterprise Products Partners
EPD
|
+$30.3M |
| 3 |
PBCT
People's United Financial Inc
PBCT
|
+$23.8M |
| 4 |
REGI
Renewable Energy Group, Inc.
REGI
|
+$20.4M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 60.43% |
| 2 | Technology | 6.16% |
| 3 | Healthcare | 4.82% |
| 4 | Consumer Discretionary | 4.16% |
| 5 | Industrials | 3.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Protagonist Therapeutics
PTGX
$8.75B
| $228K | ﹤0.01% |
28,869
-20,891
| -42% | -$253K |
|
977
Matsons
MATX
$6.37B
| $222K | ﹤0.01% |
3,042
-32
| -1% | -$2.75K |
|
978
BioXcel Therapeutics
BTAI
$26.2M
| $219K | ﹤0.01% |
1,037
-760
| -42% | -$160K |
|
979
HCA Healthcare
HCA
$84.8B
| $219K | ﹤0.01% |
1,301
-1,798
| -58% | -$386K |
|
980
Vera Therapeutics
VERA
$2.54B
| $219K | ﹤0.01% |
+16,060
| New | +$280K |
|
981
C4 Therapeutics
CCCC
$376M
| $218K | ﹤0.01% |
+28,950
| New | +$255K |
|
982
Kilroy Realty
KRC
$4.58B
| $218K | ﹤0.01% |
+4,165
| New | +$264K |
|
983
Zumiez
ZUMZ
$320M
| $218K | ﹤0.01% |
+8,397
| New | +$283K |
|
|
HLVX
984
DELISTED
HilleVax
HLVX
| $217K | ﹤0.01% |
+19,825
| New | +$235K |
|
985
Newmark Group
NMRK
$2.73B
| $217K | ﹤0.01% |
22,447
-233
| -1% | -$2.7K |
|
986
Alcoa
AA
$11.7B
| $215K | ﹤0.01% |
4,716
-49
| -1% | -$3.18K |
|
987
American Eagle Outfitters
AEO
$2.85B
| $214K | ﹤0.01% |
19,111
-199
| -1% | -$2.81K |
|
988
Invivyd
IVVD
$180M
| $214K | ﹤0.01% |
+65,095
| New | +$204K |
|
989
Live Oak Bancshares
LOB
$1.95B
| $212K | ﹤0.01% |
6,266
-65
| -1% | -$2.69K |
|
|
SBNY
990
DELISTED
Signature Bank
SBNY
| $212K | ﹤0.01% |
1,183
-12
| -1% | -$2.69K |
|
991
Cleveland-Cliffs
CLF
$6.81B
| $211K | ﹤0.01% |
13,739
-142
| -1% | -$3.39K |
|
992
American Vanguard Corp
AVD
$73.5M
| $209K | ﹤0.01% |
+9,366
| New | +$210K |
|
993
SiriusXM
SIRI
$10B
| $209K | ﹤0.01% |
3,416
-12,204
| -78% | -$758K |
|
994
Customers Bancorp
CUBI
$2.59B
| $206K | ﹤0.01% |
6,087
-63
| -1% | -$2.56K |
|
|
SGFY
995
DELISTED
Signify Health, Inc.
SGFY
| $201K | ﹤0.01% |
+14,535
| New | +$205K |
|
|
AKRO
996
DELISTED
Akero Therapeutics
AKRO
| $196K | ﹤0.01% |
20,777
-15,207
| -42% | -$159K |
|
997
Identive
INVE
$64.6M
| $196K | ﹤0.01% |
+16,937
| New | +$212K |
|
998
ALX Oncology
ALXO
$273M
| $195K | ﹤0.01% |
24,130
-17,634
| -42% | -$192K |
|
|
FMTX
999
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $195K | ﹤0.01% |
28,359
-20,430
| -42% | -$143K |
|
|
X
1000
DELISTED
US Steel
X
| $193K | ﹤0.01% |
+10,768
| New | +$294K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, ALPS Advisors held 1,109 positions worth $10.3B, up 12% from $9.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
ALPS Advisors deployed $2.36B of net new capital in Q2 2022, opening 276 new positions and adding to 252 existing holdings. Its largest new stake was Western Midstream Partners: 24,175,389 shares worth $588M.
By sector, the portfolio is most concentrated in Energy at 60% of assets, down from 66% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Energy Transfer Partners, an estimated $71M trimmed.
- ALPS Advisors's largest Q2 2022 buy was Western Midstream Partners: 24,175,389 shares worth $588M.
- ALPS Advisors added most to Hess Midstream in Q2 2022, an estimated $80.6M increase.
- ALPS Advisors's biggest Q2 2022 reduction was Energy Transfer Partners, cutting an estimated $71M.
- ALPS Advisors fully exited People's United Financial Inc in Q2 2022, selling an estimated $23.8M.
- ALPS Advisors's ten largest holdings make up 47% of its $10.3B portfolio in Q2 2022.
- ALPS Advisors opened 276 new positions and closed 79 in Q2 2022.
- ALPS Advisors's portfolio value rose 12% quarter-over-quarter to $10.3B.
Based on ALPS Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.